Filing Details
- Accession Number:
- 0001127602-15-030341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-04 17:36:00
- Reporting Period:
- 2015-11-02
- Filing Date:
- 2015-11-04
- Accepted Time:
- 2015-11-04 17:36:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487937 | Mark Stejbach | 852 Winter St. Waltham MA 02451 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-11-02 | 18,000 | $17.30 | 37,964 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-11-02 | 15,670 | $72.00 | 22,294 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-11-02 | 2,330 | $72.51 | 19,964 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2015-11-02 | 18,000 | $0.00 | 18,000 | $17.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 70,440 | 2013-03-07 | 2022-03-07 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.39 to $72.375. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.40 to $72.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 3/7/13.
Billionaire Hedge Funds
